# Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty

> **NCT03859024** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 48 (actual)

## Conditions studied

- Pain, Postoperative
- Urethral Stricture

## Interventions

- **DRUG:** Oxycodone
- **DRUG:** Acetaminophen
- **DRUG:** Gabapentin
- **DRUG:** celebrex
- **DRUG:** Bupivacaine
- **DRUG:** Ibuprofen 800 mg
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03859024
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-22
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859024, "Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03859024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*